Innoviva (INVA) ROIC: History & Chart

Name: Innoviva, Inc. (INVA) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Innoviva, Inc.(INVA)

Biotechnology · Burlingame, CA

$20.69+0.04 (+0.22%)

Delayed quote: Oct 6, 2026, 9:40 AM EDT

Compare

About Innoviva, Inc.

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.

Burlingame, CA

159 employees

www.inva.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Pavel Raifeld

View full financials

INVA Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

8.36%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

1.96%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

6.00%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

12.11%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

24.40%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

13.90%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

-0.76%

CURRENT VS TTM AVG

+325.82%

CURRENT VS 3Y AVG

+39.35%

CURRENT VS 5Y AVG

-30.92%

CURRENT VS 10Y AVG

-65.72%

CURRENT VS 15Y AVG

-39.82%

CURRENT VS 20Y AVG

+1193.94%

SECTOR MEDIAN · HEALTHCARE

-29.43%

median of 512 covered companies

CURRENT VS SECTOR MEDIAN

+128.42%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Innoviva, Inc. (INVA)	$1.53B	8.36%	1.96%	6.00%	12.11%
Eton Pharmaceuticals, Inc. (ETON)vs ›	$1.52B	20.41%	-2.25%	-13.09%	-29.56%
GH Research PLC (GHRS)vs ›	$1.51B	-19.87%	-24.87%	-20.19%	-15.68%
Certara, Inc. (CERT)vs ›	$1.57B	0.59%	0.35%	-0.10%	-0.25%
Braveheart Bio, Inc. (BRVE)vs ›	$1.48B	N/A	N/A	N/A	N/A
Healthcare Services Group, Inc. (HCSG)vs ›	$1.47B	16.83%	6.43%	6.32%	5.53%
AnaptysBio, Inc. (ANAB)vs ›	$1.43B	47.55%	-5.71%	-17.68%	-14.30%
ANI Pharmaceuticals, Inc. (ANIP)vs ›	$1.65B	9.26%	2.84%	1.55%	-0.61%
Inhibrx Biosciences Inc. (INBX)vs ›	$1.40B	-99.35%	-175.72%	-121.81%	-100.94%
Kailera Therapeutics, Inc. (KLRA)vs ›	$1.40B	-24.52%	-24.52%	-24.52%	-24.52%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Innoviva, Inc. (INVA)

$1.53B

8.36%

1.96%

6.00%

12.11%

Eton Pharmaceuticals, Inc. (ETON)vs ›

$1.52B

20.41%

-2.25%

-13.09%

-29.56%

GH Research PLC (GHRS)vs ›

$1.51B

-19.87%

-24.87%

-20.19%

-15.68%

Certara, Inc. (CERT)vs ›

$1.57B

0.59%

0.35%

-0.10%

-0.25%

Braveheart Bio, Inc. (BRVE)vs ›

$1.48B

N/A

Healthcare Services Group, Inc. (HCSG)vs ›

$1.47B

16.83%

6.43%

6.32%

5.53%

AnaptysBio, Inc. (ANAB)vs ›

$1.43B

47.55%

-5.71%

-17.68%

-14.30%

ANI Pharmaceuticals, Inc. (ANIP)vs ›

$1.65B

9.26%

2.84%

1.55%

-0.61%

Inhibrx Biosciences Inc. (INBX)vs ›

$1.40B

-99.35%

-175.72%

-121.81%

-100.94%

Kailera Therapeutics, Inc. (KLRA)vs ›

$1.40B

-24.52%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The return on invested capital (ROIC) for INVA stock is 8.36%.

Is Innoviva, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 8.36% is 31% below its 5-year average of 12.11%, near the low end of its 5-year range (-0.87%–36.50%).

What is the TTM average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The TTM average return on invested capital (ROIC) for INVA stock is 1.96%.

What is the 3Y average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The 3Y average return on invested capital (ROIC) for INVA stock is 6.00%.

What is the 5Y average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The 5Y average return on invested capital (ROIC) for INVA stock is 12.11%.

What is the 10Y average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The 10Y average return on invested capital (ROIC) for INVA stock is 24.40%.

What is the 15Y average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The 15Y average return on invested capital (ROIC) for INVA stock is 13.90%.

What is the 20Y average return on invested capital (ROIC) for Innoviva, Inc. (INVA)?

The 20Y average return on invested capital (ROIC) for INVA stock is -0.76%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	8.36%
2026-03-31	2.93%
2025-12-31	-0.87%
2025-09-30	-0.73%
2025-06-30	0.12%
2025-03-31	8.76%
2024-12-31	8.63%
2024-09-30	12.22%
2024-06-30	11.30%
2024-03-31	7.85%
2023-12-31	7.79%
2023-09-30	6.02%
2023-06-30	5.63%
2023-03-31	10.31%
2022-12-31	13.09%
2022-09-30	18.01%
2022-06-30	27.49%
2022-03-31	28.10%
2021-12-31	33.75%
2021-09-30	33.38%
2021-06-30	36.50%
2021-03-31	24.98%
2020-12-31	26.81%
2020-09-30	27.98%
2020-06-30	27.11%
2020-03-31	28.34%
2019-12-31	28.08%
2019-09-30	37.16%
2019-06-30	38.88%
2019-03-31	42.59%
2018-12-31	43.92%
2018-09-30	83.19%
2018-06-30	63.21%
2018-03-31	71.50%
2017-12-31	51.34%
2017-09-30	40.42%
2017-06-30	39.64%
2017-03-31	31.95%
2016-12-31	29.72%
2016-09-30	24.67%
2016-06-30	18.85%
2016-03-31	12.82%
2015-12-31	7.69%
2015-09-30	3.38%
2015-06-30	-0.79%
2015-03-31	-3.86%
2014-12-31	-6.68%
2014-09-30	-8.01%
2014-06-30	-7.13%
2014-03-31	-6.55%
2013-12-31	-9.28%
2013-09-30	-12.43%
2013-06-30	-18.63%
2013-03-31	-23.56%
2012-12-31	-3.84%
2012-09-30	-5.21%
2012-06-30	-3.87%
2012-03-31	-1.25%
2011-12-31	-51.43%
2011-09-30	-37.80%
2011-06-30	-30.86%
2011-03-31	-27.85%
2010-12-31	-26.88%
2010-09-30	-45.25%
2010-06-30	-41.22%
2010-03-31	-38.68%
2009-12-31	-56.24%
2009-09-30	-49.09%
2009-06-30	-42.42%
2009-03-31	-42.72%
2008-12-31	-45.65%
2008-09-30	-52.71%
2008-06-30	-54.34%
2008-03-31	-58.67%
2007-12-31	-158.20%
2007-09-30	-124.27%
2007-06-30	-123.15%
2007-03-31	-97.23%
2006-12-31	-88.30%
2006-09-30	-76.38%
2006-06-30	-67.71%
2006-03-31	-61.10%
2005-12-31	-84.06%
2005-09-30	-84.65%
2005-06-30	-59.69%
2005-03-31	-51.30%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

8.36%

2026-03-31

2.93%

2025-12-31

-0.87%

2025-09-30

-0.73%

2025-06-30

0.12%

2025-03-31

8.76%

2024-12-31

8.63%

2024-09-30

12.22%

2024-06-30

11.30%

2024-03-31

7.85%

2023-12-31

7.79%

2023-09-30

6.02%

2023-06-30

5.63%

2023-03-31

10.31%

2022-12-31

13.09%

2022-09-30

18.01%

2022-06-30

27.49%

2022-03-31

28.10%

2021-12-31

33.75%

2021-09-30

33.38%

2021-06-30

36.50%

2021-03-31

24.98%

2020-12-31

26.81%

2020-09-30

27.98%

2020-06-30

27.11%

2020-03-31

28.34%

2019-12-31

28.08%

2019-09-30

37.16%

2019-06-30

38.88%

2019-03-31

42.59%

2018-12-31

43.92%

2018-09-30

83.19%

2018-06-30

63.21%

2018-03-31

71.50%

2017-12-31

51.34%

2017-09-30

40.42%

2017-06-30

39.64%

2017-03-31

31.95%

2016-12-31

29.72%

2016-09-30

24.67%

2016-06-30

18.85%

2016-03-31

12.82%

2015-12-31

7.69%

2015-09-30

3.38%

2015-06-30

-0.79%

2015-03-31

-3.86%

2014-12-31

-6.68%

2014-09-30

-8.01%

2014-06-30

-7.13%

2014-03-31

-6.55%

2013-12-31

-9.28%

2013-09-30

-12.43%

2013-06-30

-18.63%

2013-03-31

-23.56%

2012-12-31

-3.84%

2012-09-30

-5.21%

2012-06-30

-3.87%

2012-03-31

-1.25%

2011-12-31

-51.43%

2011-09-30

-37.80%

2011-06-30

-30.86%

2011-03-31

-27.85%

2010-12-31

-26.88%

2010-09-30

-45.25%

2010-06-30

-41.22%

2010-03-31

-38.68%

2009-12-31

-56.24%

2009-09-30

-49.09%

2009-06-30

-42.42%

2009-03-31

-42.72%

2008-12-31

-45.65%

2008-09-30

-52.71%

2008-06-30

-54.34%

2008-03-31

-58.67%

2007-12-31

-158.20%

2007-09-30

-124.27%

2007-06-30

-123.15%

2007-03-31

-97.23%

2006-12-31

-88.30%

2006-09-30

-76.38%

2006-06-30

-67.71%

2006-03-31

-61.10%

2005-12-31

-84.06%

2005-09-30

-84.65%

2005-06-30

-59.69%

2005-03-31

-51.30%

Return on Invested Capital (ROIC): 8.36%

INVA Return on Invested Capital (ROIC)

INVA Average Return on Invested Capital (ROIC) Chart

INVA Current vs Average Return on Invested Capital (ROIC) Chart

INVA Return on Invested Capital (ROIC) Metrics

INVA Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

INVA Return on Invested Capital (ROIC) History

Related Metrics